BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Biotech Matchmaking Event - Cambridge Gravity &amp\; Biotech compa
 nies
DTSTART:20230302T174500Z
DTEND:20230302T223000Z
UID:TALK197782@talks.cam.ac.uk
CONTACT:Dr Alexandra Huener
DESCRIPTION:Are you interested in working for a biotech company?\n\nThis e
 vent aims to matchmake students/postdocs with biotech firms\, making conne
 ctions that may lead to opportunities for placement.\nThis event is organi
 sed by Cambridge Gravity in collaboration with the Milner Therapeutics Ins
 titute. \n\nThe biotech companies at this matchmaking event have been invi
 ted from the Milner Institute’s affiliated company network\, and from st
 art-up companies within the Milner Bio-Incubator Frame Shift.\n\n\nThis ev
 ent is free to attend. Aimed at early-career life scientists (PhD students
  and postdocs)\, it is an opportunity to view short presentations from\, a
 nd network with\, biotech companies in Cambridge\, as well as to meet like
 -minded PhD students and postdocs.\n\n\nPROGRAMME\n17:45 – 18:00 Registr
 ation\n18:00 – 18:15 Welcome by Prof Tony Kouzarides\n18:15 – 19:45 Pr
 esentations of Biotech Companies\n19:45 – 22:30 Networking session\n\n\n
 About Cambridge Gravity\nCambridge Gravity inspires and supports scientist
 s to achieve their full potential in academia\, industry and entrepreneurs
 hip: a gateway into pharma\, biotech and company building.\nWebsite: http:
 //www.gravity.cam.ac.uk\n\n\nAbout The Milner Therapeutics Institute\nThe 
 Milner Therapeutics Institute (MTI) is a biomedical institute and acts as 
 a catalyst and a driver\, forming dynamic partnerships to unlock the power
  of emerging discoveries.\n\nThe institute promotes interactions between a
 ffiliated companies and academic\, pharmaceutical or bio-technology partne
 rs\, with the aim of building a cohesive community with an aligned vision.
 \n
LOCATION:Graduate Hotel Cambridge
END:VEVENT
END:VCALENDAR
